MaxCyte (MXCT) Stock Chart & Stock Price History GBX 161.15 -6.35 (-3.79%) As of 05/23/2025 12:12 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MaxCyte Stock Price Performance The MaxCyte (MXCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 55.85%, with a year-to-date return of -49.83%. In the past month, the stock has decreased 23.99%, reflecting recent market activity. As of the latest close, MaxCyte traded at GBX 161.15 with a market cap of £212.73 million and volume of 21,238 shares. Five years ago, the stock traded at GBX 167.50, representing a 3.79% decrease over that period. At the time, it had a market cap of £100.43 million and a volume of 20,434 shares. Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.39%1 Month Performance-23.99%3 Month Performance-45.29%Year-To-Date Performance-49.83%1 Year Performance-55.85%5 Year Performance-3.79% MXCT Stock Chart for Sunday, May, 25, 2025 MXCT Chart by TradingView MaxCyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025GBX 165GBX 161.15-2.33%GBX 172.25GBX 161.1521,238 shs£212.73 million05/22/2025GBX 165GBX 165GBX 166.90GBX 165136,114 shs£217.81 million05/21/2025GBX 166.80GBX 165-1.08%GBX 175GBX 165405,781 shs£217.81 million05/20/2025GBX 166.90GBX 166.80-0.06%GBX 170GBX 166.804,083 shs£220.18 million05/19/2025GBX 165GBX 166.90+1.15%GBX 173.90GBX 16523,335 shs£220.32 million05/16/2025GBX 161.50GBX 165+2.17%GBX 172GBX 16041,396 shs£217.81 million05/15/2025GBX 166GBX 161.50-2.71%GBX 170GBX 161.5012,344 shs£213.19 million05/14/2025GBX 172GBX 166-3.49%GBX 177GBX 16517,771 shs£219.13 million05/13/2025GBX 177GBX 172-2.82%GBX 179GBX 17015,950 shs£227.05 million05/12/2025GBX 180GBX 177-1.67%GBX 178.90GBX 17599,978 shs£233.65 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025GBX 196GBX 180-8.16%GBX 180.15GBX 17759,004 shs£237.61 million05/08/2025GBX 196GBX 196GBX 210GBX 1966,882 shs£258.73 million05/07/2025GBX 196GBX 196GBX 205GBX 1964,094 shs£258.73 million05/06/2025GBX 205GBX 196-4.39%GBX 206GBX 19619,196 shs£258.73 million05/05/2025GBX 205GBX 205GBX 212GBX 20011,259 shs£270.61 million05/02/2025GBX 214GBX 205-4.21%GBX 212GBX 20011,259 shs£270.61 million05/01/2025GBX 212GBX 214+0.94%GBX 218GBX 21011,595 shs£282.49 million04/30/2025GBX 212.20GBX 212-0.09%GBX 212GBX 21020,024 shs£279.85 million04/29/2025GBX 206GBX 212.20+3.01%GBX 215GBX 21212,398 shs£280.11 million04/28/2025GBX 212GBX 206-2.83%GBX 220GBX 2063,149 shs£271.93 million04/25/2025GBX 212GBX 212GBX 212GBX 207.8015,002 shs£279.85 million04/24/2025GBX 206.50GBX 212+2.66%GBX 212GBX 20620,063 shs£279.85 million Related Companies Resolute Mining Stock Chart Ocean Wilsons Stock Chart PayPoint Stock Chart Chesnara Stock Chart TruFin Stock Chart Staffline Group Stock Chart Creightons Stock Chart Arcontech Group Stock Chart Neo Energy Metals Stock Chart MAST Energy Developments Stock Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (LON:MXCT) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
